Cloud Pharmaceuticals forms Drug Design Collaboration with GSK
Credit: Cloud Pharmaceuticals
Cloud Pharmaceuticals, Inc., an Artificial Intelligence-driven drug design and development company, announced they have entered into drug discovery collaboration with GlaxoSmithKline (GSK). Cloud will design novel small-molecule agents to GSK specified targets. Cloud will use its proprietary AI-driven process to design the molecules.
Ed Addison, CEO of Cloud Pharmaceuticals, said, “Application of Cloud Pharmaceuticals technology has been proven to dramatically shorten the time from target validation to lead molecule. We believe this agreement validates the strength of this process and reinforces the value we can offer accelerate the discovery of novel, high-quality drug candidates.”
Don Van Dyke, COO of Cloud and their lead in this collaboration added, “It is estimated that the traditional discovery process to arrive at a clinical candidate molecule takes greater than 5 years. Cloud has consistently been able to reduce that to a matter of a few months.”
Cloud Pharmaceuticals has designed active molecules with academic and commercial partners against a broad variety of drug targets and has published several papers to document its success. Cloud’s proprietary AI-driven process delivers completely novel molecules that have been tailored to the unique characteristics of each drug target.
Biometric System Measures Brainwaves, Creates Brain PasswordNews
The “brain password” could have implications in banking, law enforcement, airport security and other areas.READ MORE
Cryo-EM Reveals Interaction Between Major Drug TargetsNews
For the first time, scientists have visualized the interaction between two critical components of the body's vast cellular communication network, a discovery that could lead to more effective medications with fewer side effects for conditions ranging from migraine to cancer.READ MORE
RedSeed Ventures Financially Supports the Innovative SME with 2.5 Million EuroNews
New partners are joining Pasquale Fedele, the inventor of BrainControl, who gained a total of 2.5 million Euro in a round of funding led by the Italian based investment firm RedSeed Ventures.READ MORE
Comments | 1 ADD COMMENT
Walker Tracy | Jun 05, 2018
I am very much delighted to every viewers that is reading this,i want to inform the whole public of how me and my lover got cured from herpes simplex virus,i was diagnosed of herpes since 3 years ago and also find out that my herpes virus also effected my lover,this Virus started circulating all over our body, and we have also taken treatment from our doctor,few weeks back i came on the net to see if i will be able to get any information as to cure this Virus, on my search i saw various testimony of someone who was healed from herpes simplex virus by the great man called Dr OMOAREBUN and i told my lover about it and without any hesitation, we contacts his mail: firstname.lastname@example.org we wrote him and he guided us,we asked him for solutions and he started the remedies for the both of us and indeed 1 week after me and my lover started using the medicine, we were completely cured no doubt was found on my body and of my lover,so dear viewer why wasting your time living with this STD Virus you can contact him now any kinds of disease,contact his Email email@example.com